SOROL CITRATE (POWDER)
(and dosage form):
SOROL CITRATE (POWDER)
14 g dissolved in 500 mL water gives the following concentration:
|Each 14 g contains:|| |
|Sodium (Na+ )
|| 90 mmol/L|
|| 20 mmol/L|
|Chloride (Cl- )
|| 80 mmol/L|
|| 30 mmol/L|
|| 111 mmol/L|
A.24 (Mineral substitutes, electrolytes).
The electrolytes in Sorol Citrate powder when dissolved in water to form a hypotonic solution will replenish low levels in the body. The solution is absorbed from the gastro-intestinal tract.
As a hypotonic solution in the treatment of diarrhoea, and gastro-enteritis, replacing the ions sodium, potassium and chloride in the body after excessive fluid and electrolyte loss.
Sorol Citrate should not be administered to patients with glucose-galactose malabsorbtion syndrome. Care should be exercised when given to patients with renal failure and diabetes insipidus. Should not be given to patients with anuria.
DOSAGE AND DIRECTIONS FOR USE:
Dissolve the contents of one 14 g sachet in 500 mL of previously boiled and cooled water. The solution should be given hourly in quantities sufficient to provide for the fluid loss, preferably as directed by a physician. In children with acute diarrhoea this solution must be used as indicated by thirst. Any unused solution must be discarded after 24 hours. Do not exceed 1L solution per 24 hours.
SIDE EFFECTS AND SPECIAL PRECAUTIONS:
Glucose intolerance may occur in some patients with diarrhoea. Sodium salts should be used with caution in patients with cardiac failure, hypertension, impaired renal function, peripheral and pulmonary oedema and in toxaemia of pregnancy.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Overdosage of glucose may cause nausea and vomiting.
Overdosage of potassium chloride may cause hyperkalaemia. with paraesthesia of the extremities, listlessness, mental confusion, weakness, paralysis, hypotension, cardiac arrhythmia, heart block and cardiac arrest.
Overdosage of sodium may cause hypernatraemia, symptoms of which may include restlessness, weakness, thirst, reduced salivation and lachrymation, swollen tongue, flushing of skin, pyrexia, dizziness, headache, oliguria, hypotension, tachycardia, delirium, hyperpnoea and respiratory arrest.
Treatment is symptomatic and supportive.
White crystalline powder.
Sachets 14 g each.
Store in a cool, dry place, below 30°C
Keep out of reach of Children. Store solution in the refrigerator and discard any unused solution after 24 hours.
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
DISMED PHARMACEUTICAL (PTY) LTD (Reg No 98/04386/07)
Tillbury Business Park
DATE OF PUBLICATION:
21 August 2000
MARKETED BY RANBAXY (SA) (PTY) LTD
New addition to this site: November 2006
Source: Pharmaceutical Industry
SAEPI HOME PAGE
TRADE NAME INDEX
GENERIC NAME INDEX
Information presented by Malahyde Information Systems © Copyright 1996-2006